Dow jumps 470 points to a record as another potentially effective vaccine fuels recovery hope; European stocks close higher on hopes of an effective Covid-19 vaccine; BELEX15 ends with minor change 
U.S. stocks rose on Monday after preliminary coronavirus vaccine data from Moderna further lifted expectations of a strong economic recovery. The Dow Jones Industrial Average gained 470.63 points, or 1.6%, to close at 29,950.44. The 30-stock Dow logged intraday and closing record highs. The S&P 500 climbed 1.2% to 3,626.91, posting an all-time closing high. The Nasdaq Composite advanced 0.8% to 11,924.13. 
uropean stocks closed higher on Monday as hopes for an effective coronavirus vaccine were further boosted by positive news from Moderna.

The pan-European Stoxx 600 closed up by 1.3% provisionally, with oil and gas stocks jumping 4.2% to lead gains as almost all sectors and major bourses remained in positive territory. 
In corporate news, Spanish financial group BBVA has agreed to sell its U.S. business, BBVA USA Bancshares, to PNC Financial Services Group for $11.6 billion. BBVA shares jumped more than 15% by afternoon trading, while compatriot Banco de Sabadell also gained more than 24%. 

BELELX15 ended one more session with only symbolic 0.1% gain. The most active name was Alfa Plam, with RSD 2.5m in volume. Tehnogas was a top gainer among bigger names, with 3.5% jump. 
According to SORS data for October, y-o-y inflation stayed unchanged from September (1.8%), which is in line with NBS expectations. In monthly terms, consumer prices inched up 0.1% in October, driven mainly by the prices of clothing and footwear, vegetables and processed food. The strongest effects in the opposite direction came from the seasonally lower fruit prices and cheaper petroleum products. 
Source: CNBC, Ilirika